NASDAQ:PASG

Passage Bio Stock Insider Trading

etoro logo Buy PASG
*Your capital is at risk
$5.97
+0.0750 (+1.27%)
At Close: Jun 03, 2026

Passage Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 36.45. In total, the insiders bought 7.11M and sold 3.47M PASG shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
36.45
Buy 7.11M shares
Sell 3.47M shares
54% Buy Activity
Moderate Positive Correlation
Buy Signal Medium Confidence
Mar 16, 2026

Analysis Breakdown:

  • Supported by a positive Insider Power Score of 36.45.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 13, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 17 986
Value: $11.5K
Jan 10, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 126 209
Value: $83.3K
Jan 10, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 126 209
Value: $83.3K
Jan 08, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 75 007
Value: $51.0K
Jan 08, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 75 007
Value: $51.0K
Jan 07, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 52 536
Value: $37.3K
Jan 07, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 52 536
Value: $37.3K
Jan 06, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 19 481
Value: $15.0K
Jan 06, 2025
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 19 481
Value: $15.0K
Dec 27, 2024
Buy
Common stock, $0.0001 par value per share
P-Purchase
Lynx1 Capital Management Lp
10 Percent Owner
10% Owner 373 645
Value: $241.0K
Dec 27, 2024
Buy
Common stock, $0.0001 par value per share
P-Purchase
Lynx1 Capital Management Lp
10 Percent Owner
10% Owner 373 645
Value: $241.0K
Dec 20, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 230 321
Value: $138.2K
Dec 20, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 230 321
Value: $138.2K
Dec 11, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 80
Value: $64
Dec 11, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 80
Value: $64
Dec 10, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 8 015
Value: $6K
Dec 10, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 8 015
Value: $6K
Dec 09, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 54 181
Value: $45.5K
Dec 09, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 54 181
Value: $45.5K
Dec 06, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 20 903
Value: $17.1K
Dec 06, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 20 903
Value: $17.1K
Dec 04, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 76 200
Value: $60.2K
Dec 04, 2024
Sell
Common Stock
S-Sale
Orbimed Advisors Llc
10 Percent Owner
10% Owner 76 200
Value: $60.2K
Nov 26, 2024
Buy
Common Stock
P-Purchase
Lynx1 Capital Management Lp
10 Percent Owner
10% Owner 167 055
Value: $118.2K
Nov 25, 2024
Buy
Common stock, $0.0001 par value per share ("Common Stock")
P-Purchase
Lynx1 Capital Management Lp
10 Percent Owner
10% Owner 259 998
Value: $146.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PASSAGE BIO, INC.
Passage Bio
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE